| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,203 |
14,149 |
$1.93M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
10,564 |
10,253 |
$1.61M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,224 |
7,853 |
$1.42M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,693 |
6,692 |
$1.08M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,997 |
10,981 |
$628K |
| 99460 |
|
2,321 |
2,320 |
$357K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,797 |
2,778 |
$326K |
| 99462 |
|
1,803 |
1,447 |
$120K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,603 |
2,540 |
$74K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,727 |
1,693 |
$63K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
519 |
489 |
$44K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,701 |
1,700 |
$26K |
| 83655 |
|
2,060 |
2,060 |
$23K |
| 87430 |
|
1,055 |
1,034 |
$16K |
| 87634 |
|
250 |
249 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,094 |
1,069 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
286 |
282 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
165 |
164 |
$14K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
105 |
105 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
402 |
397 |
$13K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
480 |
480 |
$9K |
| 87807 |
|
716 |
691 |
$9K |
| 99188 |
|
345 |
345 |
$7K |
| 85018 |
|
2,341 |
2,340 |
$5K |
| 87420 |
|
396 |
384 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
123 |
120 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
47 |
41 |
$2K |
| A7037 |
Tubing used with positive airway pressure device |
71 |
71 |
$2K |
| 96380 |
|
14 |
14 |
$377.98 |
| 96381 |
|
13 |
13 |
$264.38 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
109 |
107 |
$13.23 |
| 90656 |
|
37 |
37 |
$0.03 |
| 90670 |
|
6,098 |
6,096 |
$0.01 |
| 96160 |
|
660 |
651 |
$0.00 |
| 90700 |
|
559 |
559 |
$0.00 |
| 90648 |
|
3,996 |
3,996 |
$0.00 |
| 90710 |
|
1,730 |
1,730 |
$0.00 |
| 90633 |
|
2,578 |
2,577 |
$0.00 |
| 90380 |
|
12 |
12 |
$0.00 |
| 90680 |
|
5,114 |
5,112 |
$0.00 |
| 90686 |
|
1,802 |
1,798 |
$0.00 |
| 90677 |
|
823 |
822 |
$0.00 |
| 90698 |
|
962 |
962 |
$0.00 |
| 90723 |
|
2,654 |
2,654 |
$0.00 |
| 90697 |
|
844 |
844 |
$0.00 |
| 90381 |
|
15 |
15 |
$0.00 |
| 90696 |
|
55 |
55 |
$0.00 |